GENSCO® TRENDING
Gensco Pharma® Acquires Global Rights and IP for RizaFilm® and RizaPort® May 13, 2025 Featured, Industry, Press Release, Product Update - Gensco Pharma acquires global rights to RizaFilm® and RizaPort®, with a U.S. migraine treatment launch planned for Q4 2025 and global expansion ahead. more...
LOOKING TO THE FUTURE
Launching in Q4 2025, RizaFilm® delivers fast, water-free migraine relief through novel oral dissolvable film (ODF) technology.
- Gensco Pharma® Acquires Global Rights and IP for RizaFilm® and RizaPort® May 13, 2025 Featured, Industry, Press Release, Product Update - Gensco Pharma acquires global rights to RizaFilm® and RizaPort®, with a U.S. migraine treatment launch… more...
- Gensco® Pharma Announces RizaFilm® Commercialization Update in the United States September 26, 2023 Featured, Industry, Press Release, Product Update - Gensco® Pharma, a specialty pharmaceutical company, in partnership with IntelGenx is announcing the anticipated launch… more...
- Skin Tears Treatment Market to Observe Strong Development by 2018-2026 April 15, 2019 Articles, Featured, Industry - [To download a printable version of this article, click here] MARKET RESEARCH April 12, 2019… more...
- Gensco® Pharma Partners with IntelGenx to Launch and Commercialize RIZAFILM® (U.S. market name for RIZAPORT® — Rizatriptin Oral Film) in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in… more...
- AAP Issues Flu Vaccine Recommendations for 2018-2019 September 6, 2018 Articles, Industry - All children should receive the flu shot as soon as it is available: AAP [To… more...
- An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years November 9, 2017 Clinical, Research - more...
- Now Available Through Federal Supply Schedule (FSS) September 26, 2017 Featured, Press Release, Product Update - Contract #V797D-70219 The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Pain Associated with… more...
- Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form… more...
